TRACON Pharmaceuticals Gross Profit

TRACON Pharmaceuticals (TCON) currently reports a gross profit of $3.2M as of June 2024. That compares with $9M in the prior-year period — down 64.5% year over year. That is below the Healthcare sector average of $66B. Use the charts on this page to explore TRACON Pharmaceuticals's gross profit history and peer comparisons.

TRACON Pharmaceuticals's gross profit decreased from $9M to $3.2M — a 64.5% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

TRACON Pharmaceuticals's gross profit of $3.2M is lower than the Healthcare sector average of $66B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

TRACON Pharmaceuticals reported $3.2M in gross profit as of June 2024. That compares with $9M in the prior-year period — down 64.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $3.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $66B. From there, open related valuation or income-statement pages for TRACON Pharmaceuticals, and consider following TCON for alerts when major investors trade the stock.